Reuters -- French biotech company Neovacs on Friday lowered its capital raising ambitions for an initial public offering (IPO) this month to 11 million euros, instead of the 20 million euros previously sought.
Reuters -- French biotech company Neovacs on Friday lowered its capital raising ambitions for an initial public offering (IPO) this month to 11 million euros, instead of the 20 million euros previously sought.
